HCL Technologies has now collaborated with the cloud service provider oracle Health Firm arm to accelerate the drug trials and reduce the cost of the process of development, according to the report revealed.
Oracle Health Services will now be going to use the HCL faster intelligent trials solution in collaboration with the Oracle health Sciences Mobile Health connector cloud service, according to the report.
“The collaboration between Oracle Health Sciences and HCL enables clinical teams to establish digitally-enabled clinical trial processes and new digital trial methods such as remote patient monitoring,” Jim Streeter, global vice president, product strategy for Oracle Health Sciences, said.
HCL claims that the FIT solution can be used in a wide range of cases which includes improving patient engagement, monitoring patient safety, collecting patient-reported outcomes, conducting e-visits, improving medication adherence at the time of clinical trials to reduce patient and site burden.
The solution can also be applied to drugs that are already launched commercially, such as gathering real world, remote patient monitoring, or as an accompanying application for the digital therapies.
HCL as of now has claimed that it has experience of supporting approx. Fifty thousand studies of more than 170000 sites across the globe. HCL even supports centers can even reportedly handle more than 400000 requests from investigators, nurses, subjects and sites for clinical trials sponsored by large global pharmaceutical companies as well as small biotech or even the medical devices companies.
